InvestorsHub Logo
Followers 12
Posts 671
Boards Moderated 0
Alias Born 10/12/2016

Re: HouseofCards post# 177521

Thursday, 08/05/2021 10:56:04 AM

Thursday, August 05, 2021 10:56:04 AM

Post# of 232960
HouseofCards wrote:

Couldn't you literally say this about every biotech stock before their first approval? HIV hit the primary endpoint with stat sig and have attempted to address all of the issues the FDA had with the first BLA. They've revised their CD12 trial to include more patients and more doses, mTNBC phase 2 results look promising, LH phase 2 results look promising, and we'll get NASH phase 2 results at some point before year end. Those are all reasons to think something may change. Doesn't mean they will...but they could.



Absolutely House, but what you wrote goes a bit deeper here, and for those who have followed this company for at least the last 20 months or longer, they know that Nader brought us up to a certain point, and after that from what is appears due his incompetence and arrogance has failed at every attempt for one reason or another. His statements as to his failures have been deflecting and deceiving. In the meantime he continues to pay himself handsomely for someone who has not earned a penny in revenue. What happened to the Philippines and India? One day a deal is about to happen and then you hear nothing.

House, after a while you get the idea. Whenever there is an announcement of an upcoming "call to investors and the press" the shorts come out in swarms and profit from it. Why do you think that is? (Answer: he never has anything to say of substance).

So, "no" you can't say this about "every biotech stock before their first approval."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News